Fountain Report: Regenerative Therapy Q&A with Dr. Linda Black

Gallant CEO Dr. Linda Black was featured in the August 22, 2025 issue of The Fountain Report, where she discussed how ready-to-use, allogeneic stem cell therapies differ from traditional treatments by addressing the root cause of disease. Dr. Black outlined Gallant’s pipeline—including therapies for FCGS, osteoarthritis, CKD, and atopic dermatitis—and emphasized how these FDA-regulated innovations are designed to fit seamlessly into everyday veterinary practice while improving long-term health outcomes for pets.

From The Fountain Report
Regenerative Therapy: Q&A with Linda Black